LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208454 |
001 |
ANDA |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
TABLET; ORAL |
2.5MG/500MG |
No
|
No
|
2020/05/28
(TA)
|
--
|
SUN PHARM INDS LTD |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208454 |
002 |
ANDA |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
TABLET; ORAL |
2.5MG/850MG |
No
|
No
|
2020/05/28
(TA)
|
--
|
SUN PHARM INDS LTD |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208454 |
003 |
ANDA |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
TABLET; ORAL |
2.5MG/1GM |
No
|
No
|
2020/05/28
(TA)
|
--
|
SUN PHARM INDS LTD |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208427 |
001 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG; 500MG |
No
|
No
|
2021/02/01
(TA)
|
--
|
DR REDDYS LABS LTD |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208427 |
002 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG; 850MG |
No
|
No
|
2021/02/01
(TA)
|
--
|
DR REDDYS LABS LTD |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208427 |
003 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG; 1G |
No
|
No
|
2021/02/01
(TA)
|
--
|
DR REDDYS LABS LTD |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208336 |
001 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;500MG |
No
|
No
|
2021/08/30
|
2021/08/30
|
SUNSHINE |
Prescription |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208336 |
002 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;850MG |
No
|
No
|
2021/08/30
|
2021/08/30
|
SUNSHINE |
Prescription |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208336 |
003 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;1GM |
No
|
No
|
2021/08/30
|
2021/08/30
|
SUNSHINE |
Prescription |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208473 |
002 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;850MG |
No
|
No
|
2022/04/05
(TA)
|
--
|
PRINSTON PHARMA INC |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208473 |
003 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;1GM |
No
|
No
|
2022/04/05
(TA)
|
--
|
PRINSTON PHARMA INC |
None (Tentative Approval) |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208449 |
001 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;500MG |
No
|
No
|
2023/03/30
|
2023/03/30
|
ZYDUS PHARMS |
Discontinued |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208449 |
002 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;850MG |
No
|
No
|
2023/03/30
|
2023/03/30
|
ZYDUS PHARMS |
Discontinued |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE |
208449 |
003 |
ANDA |
LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
TABLET;ORAL |
2.5MG;1GM |
No
|
No
|
2023/03/30
|
2023/03/30
|
ZYDUS PHARMS |
Discontinued |